Quality of Life Measurement in Neurodegenerative and Related Conditions

Author: Crispin Jenkinson; Michele Peters; Mark B. Bromberg  

Publisher: Cambridge University Press‎

Publication year: 2011

E-ISBN: 9781139005432

P-ISBN(Paperback): 9780521829014

Subject: R741.02 nerve pathology, etiology

Keyword: 神经病学与精神病学

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Quality of Life Measurement in Neurodegenerative and Related Conditions

Description

Patient reported outcome measures are central to the evaluation of medical care and treatment regimes. Such measures depart from traditional clinical assessments as they are based on issues known to be of importance to patients. This book outlines the development and application of a variety of such measures in a wide range of neurological conditions. Introductory chapters outline issues in the application and validation of quality-of-life measures in neurology. Subsequent chapters survey the most widely used quality-of-life instruments in Parkinson's disease, motor neurone disease, multiple sclerosis, multiple system atrophy, progressive supranuclear palsy, and Alzheimer's/dementia. A chapter on cerebral palsy deals with the particular challenges to developing outcome measures for children. The book also addresses issues relating to the translation of measures for use in cross-cultural studies, handling missing data, carer experiences of long-term conditions, and methodological challenges. Essential reading for clinicians and researchers working in the field of neurology.

Chapter

Summary

References

2 The development and validation of the Parkinson's Disease Questionnaire and related measures

Introduction

Important areas of health-related quality of life in PD

Patient-reported outcome measures

Generic measures

The Parkinson's Impact Scale (PIMS)

PDQUALIF

The Parkinson's Disease Quality of Life Questionnaire (PDQL)

The Parkinson's Disease Questionnaire (PDQ-39)

Reliability

Validity

Sensitivity to change

Cross-cultural validation

Discussion and conclusion

References

Parkinson’s Disease Quality of Life Questionnaire

3 The Multiple Sclerosis Impact Scale (MSIS-29): Initial development, subsequent revision, lessons learned

Chapter overview

Background to the development of the MSIS-29

The MSIS-29: initial development

Subsequent revision of MSIS-29 to form MSIS-29 version 2

Lessons learned

Summary

References

Multiple Sclerosis Impact Scale, version 2 (MSIS-29v2)

4 Patient-reported outcome measurement in motor neuron disease/amyotrophic lateral sclerosis – the ALSAQ-40 and ALSAQ-5

Introduction

Clinical assessment of MND

Generic measures of health status

The ALSAQ-40 disease-specific health status measure

The ALSAQ-5

Discussion

References

ALSAQ-40

5 Measuring quality of life in progressive supranuclear palsy: The PSP-QoL

Introduction

Development of the PSP-QoL

Conclusion

References

The Health-Related Quality of Life questionnaire for Patients with Progressive Supranuclear Palsy (PSP-QoL)

6 Measuring quality of life in multiple system atrophy

Introduction

The Unified Multiple System Atrophy Rating Scale (UMSARS)

PDQ-39

The Multiple System Atrophy Quality of Life Questionnaire (MSA-QOL)

Stage One: Item generation

Stage Two: Scale development and item reduction

Stage 3: Scale evaluation and validation

Conclusion

Summary

References

MSA Quality of Life Questionnaire

7 Health-related quality of life in Huntington's disease

Introduction

Evaluating HRQoL in HD

New HRQoL measurement initiatives

The PROMIS Initiative

The Neuro-QoL Initiative

The HD-QoL initiative

The Development of the HD-QoL

Summary and Recommendations

References

8 Measuring quality of life in dementia

Conceptions of QoL in dementia

QoL measures in dementia

Source of data for QoL measurement

Featured measures

The DEMQoL

The QUALIDEM

Evolution of the field and a view to the future

References

9 Condition-specific instruments to measure the quality of life (QoL) of children and adolescents with cerebral palsy (CP)

Introduction

What is CP?

QoL versus health-related QoL

Why are researchers and clinicians interested in QoL?

Measuring QoL for children with CP

Generic versus condition-specific instruments

Child self-report versus parent-proxy report

Condition-specific measures of QoL for children and adolescents with CP DISABKIDS CP disease module

Caregiver priorities and Child Health Index of Life with Disabilities (CPCHILD)

Pediatric QoL Inventory (PedsQL) – CP Module

Cerebral Palsy Quality of Life Questionnaire for Children (CP QoL-Child)

Development of the CP QoL – Child

Thematic analysis and piloting of the CP QoL – Child

Psychometric analysis of the CP QoL – Child

Conclusion

References

Appendix 1: CP QOL-Child (Proxy)

Appendix 2: CP QOL (Self-report version)

10 Outcome measures for informal carers of individuals with neurodegenerative conditions

Generic instruments

SF-36 and SF-12

Reliability

Validity

Convergent and discriminant validity

Carer instruments

Predictive validity

Sociodemographic variables

Patient variables

Precision

Responsiveness

General Health Questionnaire

Validity

Convergent and discriminant validity

Carer instruments

Sociodemographic variables

Patient variables

Responsiveness

Carer-specific instruments

Zarit Burden Interview

Versions

Psychometrics

Reliability

Construct validity

Validity

Carer variables

Carer characteristics

Family relationship

Social support

Caring variables

Health status and quality of life

Dimension-specific

Patient variables

Patient characteristics

Type of condition

Illness severity

Patient behavior

Patient mental state

Longitudinal

Responsiveness to change

Cut-off scores

Feasibility

Floor and ceiling effects

Conclusion

References

11 Translating patient-reported outcome measures (PROMs) for cross-cultural studies

Introduction

Translation

Types of translation

Translation methods

Quality of the translation

Translators

Number of translators

Skills and background

Instructions to translators

Assessors

Reports about the translation process

Conclusion

References

12 Rasch analysis

Chapter overview

Rating scales as measurement instruments: basic principles

How rating scales work

Traditional psychometric methods for evaluating scales and Classical Test Theory

Modern psychometric methods: Rasch measurement and item response theory

Development of item response theory

Development of Rasch measurement

Item response theory and Rasch measurement: similarities and differences

Similarities

Differences

Why proponents of item response theory favor their approach

Why proponents of Rasch measurement favor their approach

Limitations of new psychometric methods

Worked example

Evaluation of the RMI using traditional psychometric methods

Evaluation of the RMI using Rasch analysis

Is the RMI to CAMS sample targeting adequate for making judgments about performance of the RMI and measurement of people in the sample with MS?

Has a measurement ruler been constructed successfully? Do the 15 RMI items map out a line on which people's mobility can be located?

Do the 15 RMI items work together to define a single variable?

Does the response to one item directly influence the response to another?

Are locations of the items stable across clinically important groups?

Have the people in the sample been measured successfully?

Are persons in the sample separated along the line defined by the items?

How valid is each person's measurement?

Comparison of results from the two analytic methods

Summing up

References

13 A method for imputing missing questionnaire data

Introduction

Data Imputation

Methods

Analysis plan

Survey design

The Questionnaire

Results

Conclusion

References

14 Individualized quality of life measurement in neurodegenerative disorders

Introduction

Unique features of neurodegenerative disorders

Clinical features of amyotrophic lateral sclerosis

Clinical features of Parkinson's disease

Clinical features of Alzheimer's disease

Challenges measuring quality of life in neurodegenerative disorders

Uses of quality of life instruments

Quality of life definitions and measurement instruments

Health-related quality of life instruments

Existential quality of life instruments

Disease-specific and domain-specific quality of life instruments

Individualized quality of life instruments

Qualty of life investigations in neurodegenerative disorders

Amyotrophic lateral sclerosis

Parkinson's disease

Alzheimer's Disease

Healthy subjects

Impact of the response shift

Discussion

Conclusion

References

Index

The users who browse this book also browse